| Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| RENOVARO BIOSCIENCES INC. | COO and Executive VP for R&D | Option to Purchase Common Stock | 40K | Feb 13, 2024 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
|---|---|---|---|---|---|---|---|
| RENB | RENOVARO BIOSCIENCES INC. | Feb 13, 2024 | 6 | $0 | 4 | Feb 16, 2024 | COO and Executive VP for R&D |
| RENB | Enochian Biosciences Inc | Oct 18, 2022 | 1 | $0 | 4 | Oct 27, 2022 | Executive VP for R&D |
| RENB | RENOVARO BIOSCIENCES INC. | Jul 22, 2022 | 0 | $0 | 3/A | Feb 16, 2024 | COO and Executive VP for R&D |
| RENB | Enochian Biosciences Inc | Jul 22, 2022 | 0 | $0 | 3 | Aug 18, 2022 | Executive Vice President |